Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: Expert Opinions on HIV Cure Research
   
Ask the Experts About

Women and HIVWomen and HIV
           
Rollover images to visit our other forums!
  
  • Email Email
  • Glossary Glossary


Where do you see it
Feb 10, 2003

I have read that 2003 will be the busiest year ever for new drug launches, with at least five new products (T-20, FTC, Atazanavir and two reformulations) reaching the market in North America. With these new developements, and with future developments 5,10, or 20 yrs ahead, where do you see this disease going(no longer a death sentence, chronic like diabetes?) Will those who were infected in 2002 be around to benefit from the drugs of 2032? Your expert opinion would be greatly appreciated.

Response from Dr. Sullivan

The more drugs we have in our armamentarium the better we will be able to treat all individuals infected with HIV; we now have drug combinations capable of suppressing viral replication for years and our biggest problems are focused on adherence and long term side effects of these medications; the newly developed drugs will help us design combinations of drugs that can be easily taken and are less toxic over the long term; JLS.


Previous
Aids
Next
Oh my god...

  
  • Email Email
  • Glossary Glossary


 
 
Advertisement




Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement